Biomerieux reagents and supplies for an existing biomerieux vitek 2 compact analyzer at the naval medical readiness and training command yokosuka (nmrtc yokosuka) and the branch health clinic at…
Ended Purchase Order Awarded Last action
- Contract number
- HT941025PE072
- Awardee
-
Biomerieux Japan LTD. UEI JZPDU6QCKX55
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $63,541
Award facts
- Contract value 49% obligated
-
- $63,541.00 Current, with exercised options
- $129,786.32 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Japan
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $63,541 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a $129.8K firm fixed-price purchase order to Biomerieux Japan LTD. on October 1, 2025, for reagents and consumable supplies supporting existing Biomerieux VITEK 2 Compact Analyzer systems at the Naval Medical Readiness and Training Command Yokosuka and the Branch Health Clinic at Iwakuni in Japan. The contract carries no set-aside designation and extends through September 30, 2027. Biomerieux Japan LTD., a Japanese subsidiary of France-based Biomerieux SA, specializes in in vitro diagnostic systems and microbiological testing equipment, providing mission-critical laboratory capabilities to forward-deployed U.S. military medical treatment facilities throughout the Pacific region.
This procurement represents a direct arrangement that enables the Defense Health Agency to maintain reliable diagnostic laboratory functionality at overseas naval medical installations. The VITEK 2 Compact Analyzer systems are essential antimicrobial susceptibility testing platforms used in clinical microbiology laboratories to support diagnostic capabilities for Navy Medicine personnel and eligible beneficiaries stationed in Japan. This award is part of a broader relationship between Biomerieux Japan LTD. and the Defense Health Agency, with three related purchase orders collectively valued at approximately $238.7K and all carrying completion dates through September 30, 2027, underscoring the strategic importance of sustained diagnostic equipment support for military medical operations in the region.
Description
Biomerieux reagents and supplies for an existing biomerieux vitek 2 compact analyzer at the naval medical readiness and training command yokosuka (nmrtc yokosuka) and the branch health clinic at iwakuni (BHC iwakuni).
Quick answers
Who was awarded contract HT941025PE072?
HT941025PE072 was awarded to Biomerieux Japan LTD. by Defense Health Agency (Department of Defense) on October 1, 2025.
How much is contract HT941025PE072 worth?
The government has obligated $63,541 on HT941025PE072. Its potential value, with all options, is $129,786.
Was contract HT941025PE072 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award